直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Advised a multinational tobacco company on the validity of patents related to next generation vaping products, and freedom to operate issues*

Advised a multinational tobacco company on the validity of patents related to next generation vaping products, and freedom to operate issues.

Related Professionals

Jin Ooi
Partner
London
+44 20 7864 2821
Email

Related Practices

Diligence, Licensing, and Opinions

Opinions and Counseling

Freedom to Operate Opinions

Related Industries

Consumer Goods and Services

Consumer Products

Related Experiences

Represented a leading multi-category consumer goods company in a series of UK proceedings and coordinated proceedings in Europe and beyond, on patents concerning potentially reduced-risk products including tobacco heating, vaping/e-cigarettes, and modern oral products*

Protecting business-method patents for a travel-related company

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias*

Represented a multinational corporation and technology company in two International Trade Commission (ITC) investigations, asserting multiple patents related to audio players and voice control against an audio equipment manufacturer*

Advised a global healthcare company in anticipated court proceedings seeking declarations of non-infringement related to its influenza vaccines*

Represented U.S. company in series of nullity and infringement proceedings related to consumer products*

Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer*

Advised a biotechnology company on patents covering a well-known biologic medicine for treating eye diseases*

Advised a global innovator pharma company in relation to enforcement issues surrounding its second medical use patent for a chemotherapy medication*

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP